These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11919036)

  • 21. Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland.
    Sandoval JL; Theler JM; Cullati S; Bouchardy C; Manor O; Gaspoz JM; Guessous I
    Prev Med; 2017 Oct; 103():49-55. PubMed ID: 28778819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bavarian mammography screening program].
    Willgeroth F; Baumann M; Blaser D; Crispin A; Froschauer S; de Waal J; Heywang-Köbrunner S; Hölzel D; Kääb V; Rothe R; Stich V; Thomaschewski S; Walter D
    Radiologe; 2005 Mar; 45(3):264-8. PubMed ID: 15747148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys.
    Breen N; Kessler L
    Am J Public Health; 1994 Jan; 84(1):62-7. PubMed ID: 8279613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of mammography in a national analysis compared to results in quintile- and regionally-defined samples.
    Rakowski W; Truchil R; Schneider K; Meersman S; Clark MA
    Prev Med; 2006 May; 42(5):386-9. PubMed ID: 16504279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.
    Hendrick RE; Helvie MA; Hardesty LA
    AJR Am J Roentgenol; 2014 Dec; 203(6):1379-81. PubMed ID: 25415718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The debate on breast cancer screening with mammography is important.
    Gøtzsche PC
    J Am Coll Radiol; 2004 Jan; 1(1):8-14. PubMed ID: 17411511
    [No Abstract]   [Full Text] [Related]  

  • 31. Population-Based Health Engagement Opportunities Through Breast Imaging: A Population-Based Cross-Sectional Survey.
    Narayan AK; Flores EJ; Harvey HB; Lehman CD
    J Am Coll Radiol; 2018 Oct; 15(10):1401-1407. PubMed ID: 30061047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of mammography by survivors of breast cancer.
    Andersen MR; Urban N
    Am J Public Health; 1998 Nov; 88(11):1713-5. PubMed ID: 9807544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography Use and Physician Recommendation After the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.
    Fedewa SA; de Moor JS; Ward EM; DeSantis CE; Goding Sauer A; Smith RA; Jemal A
    Am J Prev Med; 2016 May; 50(5):e123-e131. PubMed ID: 26699245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammography quality assurance.
    Korn JE
    Minn Med; 1996 Apr; 79(4):43-5. PubMed ID: 8637491
    [No Abstract]   [Full Text] [Related]  

  • 36. Mammography and clinical breast examinations among women aged 50 years and older--Behavioral Risk Factor Surveillance System, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(38):737-41. PubMed ID: 8371707
    [No Abstract]   [Full Text] [Related]  

  • 37. State legislation related to breast cancer: 1980-1994.
    Wyatt SW; Long DM; Lee NC; Henson RM; Iacino BJ
    J Public Health Manag Pract; 1996; 2(2):64-9. PubMed ID: 10186670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography screening in Italy: 2004 survey and 2005 preliminary data.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):7-20. PubMed ID: 17824359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health insurance oversight issue brief: mandated benefits: breast cancer screening coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-11. PubMed ID: 15726740
    [No Abstract]   [Full Text] [Related]  

  • 40. Mass mammography screening: using an information system to track participation and identify target populations.
    Marshburn J; Bradham DD; Studnicki J; Nemec L; Luther S; Clark RA
    Cancer Pract; 1994; 2(2):146-53. PubMed ID: 8055016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.